Skip to content
About Us
Oncolytic Viruses
Immunotherapy Combinations
R&D Facility
Team
Company News
Corporate Investor Deck
Our Technology
IVX037
IVX055
Pipeline
Scientific Presentations
Pre-clinical / discovery
Clinical
Therapeutic Strategy
Innovent Collaboration
Pipeline
Leadership Team
Board
Management Team
Investor Centre
Corporate Deck
Company Announcements
In the News
ESG
Recruitment
Contact Us
About Us
Oncolytic Viruses
Immunotherapy Combinations
R&D Facility
Team
Company News
Corporate Investor Deck
Our Technology
IVX037
IVX055
Pipeline
Scientific Presentations
Pre-clinical / discovery
Clinical
Therapeutic Strategy
Innovent Collaboration
Pipeline
Leadership Team
Board
Management Team
Investor Centre
Corporate Deck
Company Announcements
In the News
ESG
Recruitment
Contact Us
News
November 4, 2022
AFR Higher Education Award Research Commercialisation
ImmVirX nominated for AFR Higher Education Award under the Research Commercialisation category
You can read the full story
here
.
Prev
Previous
Next
Next